Lorenzo Guglielmetti

Lorenzo Guglielmetti is co-Principal Investigator of the endTB and endTB-Q trials and Director of the endTB project for MSF. He is a Medical Doctor specialized in Infectious Diseases and an Epidemiologist; his overarching goal is to improve treatment outcomes of persons with tuberculosis through clinical research. He has contributed to numerous national and international guidelines on the treatment of mycobacterial infections. Dr Guglielmetti is Chair of the Study Group on Mycobacteria (ESGMYC) of the ESCMID and Clinical Trial chair of the TBnet.